capecitabine

Type: Keyphrase
Name: capecitabine
First reported 2 hours ago - Updated 2 hours ago - 1 reports

Understanding the Impact of Results From CALGB/ SWOG 80405 and Other New Data in Colorectal Cancer

Figures:Alok A. Khorana, MDThree Takeaways in Colorectal Cancer From ASCO 2014For now, you can use either cetuximab or bevacizumab in first-line treatment of KRAS wild-type metastatic colorectal cancer. Toxicities appear to be similar, median survival ... [Published The ASCO Post - 2 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Forum Post: Capecitabine (Xeloda) starting thursday and feel like Im back to square one

Breast, secondary cancerSecondary breast cancer is cancer that has started in the breast and spread to other parts of the body. This group is for people affected by secondary breast cancer to share experiences and get support.Capecitabine (Xeloda) starting ... [Published Macmillan Cancer Support - 17 hours ago]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Revision: 3, Authorised

Entities: capecitabine
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Chemo Safety: Can Biomarkers Help?

David J. Kerr, CBE, MD, DSc, FRCP, FMedSciDisclosures August 28, 2014Hi. I am David Kerr, Professor of Cancer Medicine at the University of Oxford, in the United Kingdom. Today, I want to talk about chemotherapy safety, an issue that is becoming higher ... [Published General Medicine eJournal - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Mylan launches generic version of cancer drug

(MarketLine via COMTEX News Network) -- Mylan Inc., a generic pharmaceutical company, has launched Capecitabine tablets USP, 150mg and 500mg, the generic version of Genentech's Xeloda tablets for breast, colon and colorectal cancers.Mylan received final ... [Published PredictWallStreet - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

CAPECITABINE Tablet, Film Coated [Mylan Institutional Inc.]

Entities: capecitabine
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

OâShaughnessy Provides Fresh Insights Into Specificity in TNBC Therapy

Joyce A. O’Shaughnessy, MDAlthough no cytotoxic agents are currently correlated with specific subtypes of triple negative breast cancer (TNBC), recent findings indicate that targeting genomic stability, antimetastatic mechanisms, and protein expression ... [Published OncLive - Aug 25 2014]
First reported Aug 20 2014 - Updated Aug 21 2014 - 2 reports

Forum Post: RE: Thoughts on chemo please

> Cancer types> Bowel (colon & rectum) cancer> Bowel (Colon & Rectum) Cancer Group - Discussion Forum> Thoughts on chemo pleaseDiscussion toolsKeywordsRE: Thoughts on chemo pleaseBowel (colon & rectum) cancerA group for anyone affected by ... [Published Macmillan Cancer Support - Aug 20 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Mylan Launches Generic Xeloda® Tablets

By a News Reporter-Staff News Editor at Pharma Business Week -- Mylan Inc. (Nasdaq: MYL) announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda® Tablets. Mylan received final approval from ... [Published 4 Traders - Aug 21 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Study Modification: Capecitabine sensitivity

AUTHOR: O'Donnell PHSTUDY DATE: January 3, 2012TITLE: Identification of novel germline polymorphisms governing capecitabine sensitivity. ... [Published National Human Genome Research Institute - Aug 19 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 11 reports

Mylan launches Xeloda generic

PITTSBURGH – Mylan Inc. has released capecitabine tablets (150 mg and 500 mg), a treatment for cancer.The company said Monday that it has received final approval from the Food and Drug Administration for the product, indicated as monotherapy, adjuvant ... [Published Chain Drug Review - Aug 12 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Brain Metastases of Her2-Positive Breast Cancer: A Case of 34 Months' Remission with Lapatinib plus Capecitabine

ReferencesGroves MD: New strategies in the management of leptomeningeal metastases. Arch Neurol 2010;67:305-312.Lai R, Dang CT, Malkin MG, Abrey LE: The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. ... [Published Sexual Development - Aug 06 2014]

Quotes

...In the subjects with the highest antibody concentrations, the authors note "some patients demonstrated a strong anti-drug antibody response after about 10 days of cycle 2 dosing, with an abrupt reduction of bioavailability and increase in drug clearance."
"FIG. 1 is a graph showing the number of surviving cells of Panc-1 cells after culture in media 1-1 to 1-3 for 72 hr."

More Content

All (115) | News (87) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Understanding the Impact of Results From CALGB/... [Published The ASCO Post - 2 hours ago]
Forum Post: Capecitabine (Xeloda) starting thur... [Published Macmillan Cancer Support - 17 hours ago]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - 18 hours ago]
MacroGenics: A Late Stage Pipeline Review [Published Seeking Alpha - Aug 30 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Chemo Safety: Can Biomarkers Help? [Published General Medicine eJournal - Aug 28 2014]
AJINOMOTO : Patent Application Titled "Therapeu... [Published 4 Traders - Aug 28 2014]
Pfizer : Announces Submission of Palbociclib Ne... [Published 4 Traders - Aug 28 2014]
Mylan launches generic version of cancer drug [Published PredictWallStreet - Aug 27 2014]
CAPECITABINE Tablet, Film Coated [Mylan Institu... [Published DailyMed Drug Label Updates for the last seven ... - Aug 25 2014]
OâShaughnessy Provides Fresh Insights Into Spec... [Published OncLive - Aug 25 2014]
Forum Post: RE: Have you have Capecitabine (Xel... [Published Macmillan Cancer Support - Aug 22 2014]
Cardiovascular Toxicity Associated With Adjuvan... [Published General Medicine eJournal - Aug 21 2014]
Mylan Launches Generic Xeloda® Tablets [Published 4 Traders - Aug 21 2014]
Best to Stage Esophageal Cancer After Neoadjuva... [Published Cancernetwork.com - Aug 21 2014]
Forum Post: RE: Thoughts on chemo please [Published Macmillan Cancer Support - Aug 20 2014]
Forum Post: Thoughts on chemo please [Published Macmillan Cancer Support - Aug 20 2014]
Thymidine Phosphorylase in Metastatic Colorecta... [Published General Medicine eJournal - Aug 20 2014]
Mylan Launches Generic Precedex Sedative as Hos... [Published Pharmacy Times - Aug 19 2014]
Study Modification: Capecitabine sensitivity [Published National Human Genome Research Institute - Aug 19 2014]
Real Life: 'I was diagnosed with cancer aged 26' [Published FemaleFirst.co.uk - Aug 19 2014]
Reports from Hospital Clinic Provide New Insigh... [Published Pharmacy Choice - Aug 19 2014]
Pfizer Announces Submission of Palbociclib New ... [Published Benzinga.com - Aug 18 2014]
Pfizer Announces Submission of Palbociclib New ... [Published Wall Street Select - Aug 18 2014]
Circulating Tumor Cells in Metastatic Breast Ca... [Published The ASCO Post - Aug 15 2014]
Tackling the Heterogeneity of Triple-Negative B... [Published The ASCO Post - Aug 14 2014]
The cruel sham of “right to try” comes to Michi... [Published ScienceBlogs : Combined Feed - Aug 14 2014]
Tripathy Offers Perspective on HER2-Positive Br... [Published OncLive - Aug 13 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - 18 hours ago]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Aug 29 2014]
CAPECITABINE Tablet, Film Coated [Mylan Institu... [Published DailyMed Drug Label Updates for the last seven ... - Aug 25 2014]
Updated Date: Aug 25, 2014 EST ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.